Fresenius SE & Co. KGaA

BRSE:000332902 Stock Report

Market Cap: CHF 17.2b

Fresenius SE KGaA Valuation

Is 000332902 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of 000332902 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 000332902?

Key metric:

The above table shows the Price to Sales ratio for 000332902. This is calculated by dividing 000332902's market cap by their current revenue.
What is 000332902's PS Ratio?
PS Ratio0.8x
Sales€22.81b
Market Cap€18.56b

Price to Sales Ratio vs Peers

How does 000332902's PS Ratio compare to its peers?

The above table shows the PS ratio for 000332902 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.6x
SOON Sonova Holding
5x6.6%CHF 18.4b
STMN Straumann Holding
8x8.8%CHF 20.4b
GALE Galenica
1x4.2%CHF 3.9b
ALC Alcon
4.4x6.0%CHF 39.3b
000332902 Fresenius SE KGaA
0.8x3.6%CHF 18.6b

Price to Sales Ratio vs Industry

How does 000332902's PS Ratio compare vs other companies in the European Healthcare Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies13PS00.61.21.82.43+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price to Sales Ratio vs Fair Ratio

What is 000332902's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

000332902 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio1.7x

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/27 03:07
End of Day Share Price 2024/08/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius SE & Co. KGaA is covered by 49 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Hassan Al-WakeelBarclays
Robert BateBarclays